Tevogen Bio submits IND for T cell treatment in COVID-19
Collaboration aims to harness Tevogen’s proprietary immunotherapy platform and Dr. Neal Flomenberg’s expertise in research and the transplantation of T cells
Feature
Sickle cell and CNS results from Cyclerion
Company announces data from two clinical trials, with a mix of bad and good news
COVID-19 and trial complications
Phesi analysis details the pandemic’s impact on recruitment and the future of trials
Special Report on Metabolic Disease: Intercepting diabetes
Researchers are increasingly targeting autoimmunity rather than hyperglycemia as they search for better ways to treat type 1 diabetes
Daré Bioscience goes after bacterial vaginosis
Company announces publication of DARE-BV1 proof-of-concept study for proprietary thermosetting hydrogel formulation of clindamycin phosphate for one-time vaginal administration
Arcturus announces preclinical publication of its COVID-19 vaccine candidate
Encouraging preclinical results demonstrate a strong antibody and cellular immune response and 100-percent protection against SARS-CoV-2 infection following a single vaccination
AI accelerates hunt for COVID-19 treatments
GlobalData highlights some example of how artificial intelligence systems are handling drug repurposing to find potential COVID-19 therapies
Predicting onset of COVID-19
BioSymetrics collaborates with Janssen and Sema4 to Predict the Onset of COVID-19
Intravacc and Therapyx jointly develop the world's first prophylactic gonorrhea vaccine
Mucosal vaccine platforms offer a broader perspective also for respiratory virus vaccines, such as COVID-19 and influenza
Special Report on Stem Cells: Mother lode
Are cancer stem cells a better oncology target?
